In Vascular Biology & Thrombosis Research
The Bernd R. Binder Publication Prize was established in Memory of the founder of Technoclone Prof. Dr. Bernd R. Binder (1945-2010) to promote young scientists who have shown an outstanding contribution to the field of Vascular Biology and Thrombosis Research.
This prize underlines Technoclone's tradition in fostering and supporting innovative research in academia an outstanding contribution to the field of Vascular Biology and Thrombosis Research.
After 10 years being part of the Joint Meeting on Vascular Biology, Inflammation and Thrombosis, we are happy to announce that from 2023 on the BRB Publication Prize will be part of the European Congress on Thrombosis and Haemostasis (ECTH) https://www.ecth.org. The ECTH brings together researchers, scientists, clinicians and other healthcare professionals at the premier scientific congress in Europe around thrombosis and bleeding. It offers a comprehensive scientific and clinical education across a broad set of current and soon-to-be released studies, new findings, treatments or products.
About the BRB Publication Prize
One award of € 2,500.- to the first author of an excellent original article in the areas of Vascular Biology and Thrombosis Research published in an international peer-reviewed journal.
Applicants are first author of a publication from an independent research institution (university, public research institute, etc.) in the area of Vascular Biology and/or Thrombosis Research.
The paper must be a journal article published (in print or online) in an international peer-reviewed journal in the corresponding year.
The prize will be awarded following the recommendation of a selected prize award committee.
CONGRATULATION to the winner of the Bernd R. Binder Publication Prize 2022:
Dr. Sarajo Mohanta from Ludwig-Maximilians University Munich for his article: “Neuroimmune cardiovascular interfaces control atherosclerosis“, Nature.2022;605:152–159
The winner will be present at the Opening Ceremony of the ECTH September 13th, 2023 in Valencia Spain.
The publication prize also includes free registration at the ECTH the European Congress of Thrombosis & Haemostasis https://www.ecth.org from September, 13.-15, 2023 in Valencia, Spain and the refund of the associated travel costs.
For any further questions please contact email@example.com
Dr. Sarajo Mohanta
Neuroimmune cardiovascular interfaces control atherosclerosis
APRIL limits atherosclerosis by binding to heparan sulfate proteoglycans
Endothelial S1P1 Signaling Counteracts Infarct Expansion in Ischemic Stroke
Selective EGF-Receptor Inhibition in CD4þ T Cells Induces Anergy and Limits Atherosclerosis
Host DNases prevent vascular
Emiel van der Vorst
High-Density Lipoproteins Exert Pro-
Katrin F. Nickel
The polyphosphate-factor XII pathway
MHC Class II-Restricted Antigen
Endothelial JAM-A guides monocytes into
The interferon stimulated gene 12 inactivates vasculoprotective functions of NR4A nuclear receptors. Circulation Research 2012; 110 (8):e50-63